scholarly journals Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand

2018 ◽  
Vol 37 (2) ◽  
pp. 291-291
Author(s):  
Bunchai Chongmelaxme ◽  
Pochamana Phisalprapa ◽  
Ratree Manthaisong ◽  
Piyameth Dilokthornsakul ◽  
Nathorn Chaiyakunapruk
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Weight Reduction ◽  
Fatty Liver Disease ◽  
Cost Effective ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand

2018 ◽  
Vol 37 (2) ◽  
pp. 267-278 ◽  
Author(s):  
Bunchai Chongmelaxme ◽  
Pochamana Phisalprapa ◽  
Ratree Sawangjit ◽  
Piyameth Dilokthornsakul ◽  
Nathorn Chaiyakunapruk
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Weight Reduction ◽  
Fatty Liver Disease ◽  
Cost Effective ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the U.S. is cost effective: A comprehensive economical analysis

2020 ◽  
Vol 73 ◽  
pp. S136-S137
Author(s):  
Mazen Noureddin ◽  
Calum Jones, Msc ◽  
Eduardo Vilar Gomez ◽  
Naim Alkhouri ◽  
George Therapondos ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Cost Effective ◽  
Alcoholic Fatty Liver ◽  
Economical Analysis ◽  
Alcoholic Fatty Liver Disease ◽  
The U.S

Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population

2020 ◽  
pp. 1-8
Author(s):  
Jeniffer Danielle M. Dutra ◽  
Quelson Coelho Lisboa ◽  
Silvia Marinho Ferolla ◽  
Carolina Martinelli M. L. Carvalho ◽  
Camila Costa M. Mendes ◽  
...  
Keyword(s):  
Vitamin D ◽  
Liver Disease ◽  
Fatty Liver ◽  
Disease Severity ◽  
Fatty Liver Disease ◽  
Hypovitaminosis D ◽  
Alcoholic Fatty Liver ◽  
Vitamin D Levels ◽  
The Mean ◽  
Alcoholic Fatty Liver Disease

Abstract. Some epidemiological evidence suggests an inverse correlation between non-alcoholic fatty liver disease (NAFLD) frequency and vitamin D levels. Likewise, a beneficial effect of vitamin D on diabetes mellitus (DM) and insulin resistance has been observed, but this is an unsolved issue. Thus, we aimed to investigate the prevalence of hypovitaminosis D in a NAFLD Brazilian population and its association with disease severity and presence of comorbidities. In a cross-sectional study, the clinical, biochemical and histological parameters of 139 NAFLD patients were evaluated according to two different cut-off points of serum 25-hydroxyvitamin D levels (20 ng/mL and 30 ng/mL). The mean age of the population was 56 ± 16 years, most patients were female (83%), 72% had hypertension, 88% dyslipidemia, 46% DM, 98% central obesity, and 82% metabolic syndrome. Serum vitamin D levels were < 30 ng/mL in 78% of the patients, and < 20 ng/mL in 35%. The mean vitamin D level was 24.3 ± 6.8 ng/mL. The comparison between the clinical, biochemical and histological characteristics of the patients according to the levels of vitamin D showed no significant difference. Most patients with NAFLD had hypovitaminosis D, but low vitamin D levels were not related to disease severity and the presence of comorbidities.

Sign in / Sign up

Export Citation Format

Share Document